Furthermore, the public database Kaplan–Meier Plotter also disclosed that higher SET gene expression, which encodes oncoprotein SET, was associated with poor RFS with primary breast cancer receiving the adjuvant tamoxifen treatment (Figure 3). The gene discussed is SET; the disease is breast cancer.